Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (161-170 of 505) with videos related to

Pageof 51
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2015
Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary diseaseAdam P Garrow, Janelle Yorke, Naimat Khan, et al.
Advances in Therapy|July 17, 2020
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical TrialsRoland Buhl, Alberto de la Hoz, Wenqiong Xue, et al.
Respiratory Research|January 7, 2011
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPDKhaled Al-shair, Umme Kolsum, Rachel Dockry, et al.
European Journal of Endocrinology|July 28, 2022
Inhaled glucocorticoid-induced metabolome changes in asthmaPeter Daley-Yates, Brian Keppler, Noushin Brealey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 21, 2008
Non-invasive biomarkers and pulmonary function in smokersZoë L Borrill, Kay Roy, Rupert S Vessey, et al.
Advances in Therapy|May 29, 2020
Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO<sup>®</sup> and OTEMTO<sup>®</sup> StudiesRoland Buhl, Dave Singh, Alberto de la Hoz, et al.
Respiratory Research|September 23, 2020
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER studyDave Singh, Aida Emirova, Catherine Francisco, et al.
Respiratory Research|March 3, 2010
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthmaDave Singh, Frank Petavy, Alex J Macdonald, et al.
Allergy|September 10, 2025
Microenvironment-Driven Mast Cell Plasticity: Insights From Cytokine-Activated Gene Signatures in Skin and Respiratory DiseasesChiara Tontini, Rajia Bahri, Andrew Higham, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 6, 2023
Asthma and Rhinitis Through the Lifespan of Nonpregnant WomenChristine R Jenkins, Dave Singh, Francine M Ducharme, et al.
Pageof 51

Showing results (161-170 of 505) with videos related to

Sort By:
Pageof 51
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2015
Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary diseaseAdam P Garrow, Janelle Yorke, Naimat Khan, et al.
Advances in Therapy|July 17, 2020
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical TrialsRoland Buhl, Alberto de la Hoz, Wenqiong Xue, et al.
Respiratory Research|January 7, 2011
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPDKhaled Al-shair, Umme Kolsum, Rachel Dockry, et al.
European Journal of Endocrinology|July 28, 2022
Inhaled glucocorticoid-induced metabolome changes in asthmaPeter Daley-Yates, Brian Keppler, Noushin Brealey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 21, 2008
Non-invasive biomarkers and pulmonary function in smokersZoë L Borrill, Kay Roy, Rupert S Vessey, et al.
Advances in Therapy|May 29, 2020
Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO<sup>®</sup> and OTEMTO<sup>®</sup> StudiesRoland Buhl, Dave Singh, Alberto de la Hoz, et al.
Respiratory Research|September 23, 2020
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER studyDave Singh, Aida Emirova, Catherine Francisco, et al.
Respiratory Research|March 3, 2010
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthmaDave Singh, Frank Petavy, Alex J Macdonald, et al.
Allergy|September 10, 2025
Microenvironment-Driven Mast Cell Plasticity: Insights From Cytokine-Activated Gene Signatures in Skin and Respiratory DiseasesChiara Tontini, Rajia Bahri, Andrew Higham, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 6, 2023
Asthma and Rhinitis Through the Lifespan of Nonpregnant WomenChristine R Jenkins, Dave Singh, Francine M Ducharme, et al.
Pageof 51